Legislative reports

The Oregon Prescription Drug Affordability Board presented the 2024 generic drug report to the Oregon Legislature in accordance with Senate Bill 844. The report includes:

• Background, Page 4
  
• Authorized generics, Page 5
  
• Manufacturer strategies, Page 6
  
• Generic and biosimilar litigation, legislation, Page 9
  
• Generic and biosimilar drug pricing, Page 10
  
• Generics in other countries, Page 12
  
• Generic formulary placement, Page 13
  
• Generic drug shortages, Page 14
  
• Generic and biosimilar substitution, Page 16
  
• Conclusion, Page 17
  

View 2024 Generic Drug Report